Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-25-001794
Filing Date
2025-01-24
Accepted
2025-01-24 16:13:01
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 clnn20250108_s3.htm S-3 282954
2 EXHIBIT 5.1 ex_763338.htm EX-5.1 15158
3 EXHIBIT 23.2 ex_763339.htm EX-23.2 2433
4 FILING FEE TABLE ex_763340.htm EX-FILING FEES 17297
5 clenelogo11percent.jpg GRAPHIC 10252
6 hklogo35px.jpg GRAPHIC 8086
7 pipelinejan202524pct.jpg GRAPHIC 122421
  Complete submission text file 0001437749-25-001794.txt   513156
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-284479 | Film No.: 25554351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)